The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 31, Issue 1, Pages 47
Publisher
Springer Nature
Online
2012-09-15
DOI
10.1186/1756-9966-31-47
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD40-Activated B Cells Can Efficiently Prime Antigen-Specific Naïve CD8+ T Cells to Generate Effector but Not Memory T cells
- (2012) Mélissa Mathieu et al. PLoS One
- Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
- (2011) Takami Sato et al. IMMUNOLOGIC RESEARCH
- The immunoregulatory mechanisms of carcinoma for its survival and development
- (2011) Caigan Du et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma
- (2011) Karin U. Sorenmo et al. PLoS One
- TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
- (2010) L. Yang CURRENT MOLECULAR MEDICINE
- Biology of interleukin-10
- (2010) Robert Sabat et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Guiding the “misguided” - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
- (2010) Fang-Ping Huang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The evolving role of dendritic cells in cancer therapy
- (2010) EJ Ilett et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens
- (2009) Sang-Ki Kim et al. ANNALS OF HEMATOLOGY
- The role of B cells in the pathogenesis of graft-versus-host disease
- (2009) A. Shimabukuro-Vornhagen et al. BLOOD
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen
- (2009) S Guo et al. GENE THERAPY
- CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential
- (2008) E. Kondo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells
- (2008) Mi-Young Park et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma
- (2008) N J Mason et al. GENE THERAPY
- CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides
- (2008) Tahamtan Ahmadi et al. IMMUNOLOGY
- Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducingin vitroantigen-specific T-cell responses
- (2008) Jaewoo Lee et al. IMMUNOLOGY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Immunosuppressive mechanisms in human tumors: Why we still cannot cure cancer
- (2007) Stefanie Gross et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search